spacer
home > pmps > spring 2017 > open and close
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Open and Close

For packaging to be child-resistant, it must be difficult for a child under the age of four years and four months (52 months) to open or gain access to the contents in a reasonable period – but not challenging for an adult up to 70 years old to use properly. This is the generally accepted definition, and is used in international and European standards as well as the Code of Federal Regulations (CFR) in the US (it is worth noting at this point that child-resistant packaging is not ‘child-proof’).

Child-resistant reclosable packs were first introduced in the UK in the mid- 1970s as an American import and have achieved increasing acceptance in the UK and other EU member states over the past 40 years. In Britain, non-reclosable child-resistant packs were slow to emerge and were only standardised in 2001. As well as being subject to international, European and American standards, the use of child-resistant packs for certain products has been set out in various regulations, including the Human Medicines Regulations 2012 and the globally harmonised system of classification and labelling chemicals, which came into full force in 2015.

Since its introduction, this type of packaging has been improved and made more effective, not only in levels of resistance to opening by children but in its ease-of-use by adults. In addition, increasing and ongoing efforts have been made to create more lightweight packaging across the board.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Stephen Wilkins was appointed Chief Executive Officer of the Child-Safe Packaging Group upon its formation in 1995 and has driven its activities since then. In addition, he is Director of Davies Development and Testing and sits on a number of BSI and ISO committees concerned with developing standards for packaging. Stephen attended the University of Durham Business School, UK, where he obtained a Master’s degree in Business Administration.
spacer
Stephen Wilkins
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Domestic companies predict a 16% growth in the South Korean pharma market during CPhI Korea

CPhI Korea, organized by UBM, closed its doors in Seoul after another record-breaking event that attracted 4,300 attendees and 147 exhibitors. During the event, UBM undertook an in-depth onsite survey of both international and domestic attendees, with domestic companies reporting a headline growth in the order of 16% across the South Korean pharma economy.
More info >>

White Papers

Nasal Drug Delivery with a Focus on Chronic Rhino-Sinusitis

Aptar Pharma

Aptar Pharma have hosted a scientific roundtable on “Nasal drug delivery with a focus on chronic rhino‑sinusitis”. This international scientific forum was held in Paris, France on November 13th 2012. The roundtable was organized to explore and exchange views on the science of various forms of sinusitis and its related unmet medical needs.
More info >>

 
Industry Events

Clinical Trial Supply Forum 2018

22-24 January 2018, London, UK

In the constantly changing environment of Clinical Trial Supply, cost efficiency, end to end visibility, logistics and managing complex pipelines are STILL crucial elements that need addressing!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement